Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA CIPLA ALEMBIC PHARMA/
CIPLA
 
P/E (TTM) x 38.5 35.2 109.2% View Chart
P/BV x 2.3 4.3 52.4% View Chart
Dividend Yield % 1.7 0.4 369.1%  

Financials

 ALEMBIC PHARMA   CIPLA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-22
CIPLA
Mar-22
ALEMBIC PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,0901,083 100.6%   
Low Rs672806 83.4%   
Sales per share (Unadj.) Rs269.9269.7 100.1%  
Earnings per share (Unadj.) Rs26.231.7 82.7%  
Cash flow per share (Unadj.) Rs40.844.8 91.2%  
Dividends per share (Unadj.) Rs10.005.00 200.0%  
Avg Dividend yield %1.10.5 214.5%  
Book value per share (Unadj.) Rs266.5257.8 103.4%  
Shares outstanding (eoy) m196.56806.81 24.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.33.5 93.2%   
Avg P/E ratio x33.629.8 112.8%  
P/CF ratio (eoy) x21.621.1 102.3%  
Price / Book Value ratio x3.33.7 90.2%  
Dividend payout %38.115.8 241.9%   
Avg Mkt Cap Rs m173,172762,177 22.7%   
No. of employees `000NANA-   
Total wages/salary Rs m11,33035,299 32.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m53,058217,633 24.4%  
Other income Rs m5053,217 15.7%   
Total revenues Rs m53,563220,851 24.3%   
Gross profit Rs m8,74143,298 20.2%  
Depreciation Rs m2,86810,520 27.3%   
Interest Rs m1771,064 16.7%   
Profit before tax Rs m6,20134,933 17.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,0459,338 11.2%   
Profit after tax Rs m5,15725,595 20.1%  
Gross profit margin %16.519.9 82.8%  
Effective tax rate %16.826.7 63.0%   
Net profit margin %9.711.8 82.6%  
BALANCE SHEET DATA
Current assets Rs m29,748147,108 20.2%   
Current liabilities Rs m18,30649,129 37.3%   
Net working cap to sales %21.645.0 47.9%  
Current ratio x1.63.0 54.3%  
Inventory Days Days1163 16.8%  
Debtors Days Days66 96.7%  
Net fixed assets Rs m42,554119,415 35.6%   
Share capital Rs m3931,614 24.4%   
"Free" reserves Rs m51,982206,364 25.2%   
Net worth Rs m52,375207,977 25.2%   
Long term debt Rs m04,162 0.0%   
Total assets Rs m72,302266,523 27.1%  
Interest coverage x36.033.8 106.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.70.8 89.9%   
Return on assets %7.410.0 73.8%  
Return on equity %9.812.3 80.0%  
Return on capital %12.217.0 71.8%  
Exports to sales %43.826.2 167.0%   
Imports to sales %12.78.2 155.0%   
Exports (fob) Rs m23,25157,094 40.7%   
Imports (cif) Rs m6,72817,803 37.8%   
Fx inflow Rs m23,25160,180 38.6%   
Fx outflow Rs m6,72817,803 37.8%   
Net fx Rs m16,52342,376 39.0%   
CASH FLOW
From Operations Rs m5,52433,259 16.6%  
From Investments Rs m-3,720-18,719 19.9%  
From Financial Activity Rs m-2,174-15,998 13.6%  
Net Cashflow Rs m-370-1,323 27.9%  

Share Holding

Indian Promoters % 69.1 13.5 512.2%  
Foreign collaborators % 0.5 20.1 2.5%  
Indian inst/Mut Fund % 18.1 49.0 36.9%  
FIIs % 5.9 27.6 21.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 66.4 45.8%  
Shareholders   101,457 418,910 24.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on ALEMBIC PHARMA vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC PHARMA vs Cipla Share Price Performance

Period ALEMBIC PHARMA Cipla S&P BSE HEALTHCARE
1-Day 0.88% -0.22% 0.67%
1-Month -6.76% 7.34% 1.42%
1-Year -23.39% 13.32% -10.55%
3-Year CAGR 5.86% 37.92% 23.16%
5-Year CAGR 3.80% 13.95% 11.48%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC PHARMA share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of ALEMBIC PHARMA hold a 69.6% stake in the company. In case of Cipla the stake stands at 33.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC PHARMA and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 38.1%.

Cipla paid Rs 5.0, and its dividend payout ratio stood at 15.8%.

You may visit here to review the dividend history of ALEMBIC PHARMA, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

3 Reasons Why Sensex Rallied 1,016 Points Today(Closing)

After opening the day on a strong note, Indian share markets extended gains as the session progressed and ended near day's high.